J.t.smith & Son Pharma Limited in Croydon, CR0 2LX

Description

Data updated on: 01-11-2023

Located in 6th Floor, Amp House, Croydon CR0 2LX J.t.smith & Son Pharma Limited is a Private Limited Company issued a 06157479 registration number. It was started on 2007-03-13. This firm's SIC and NACE codes are 47730 which stands for Dispensing chemist in specialised stores. 2023-01-31 is the last time when account status updates were reported.

At present, this particular firm is presided over by one director: Bharat M., who was assigned this position 17 years ago. In order to support the directors in their duties, this firm has been utilizing the expertise of Hemlata M. as a secretary for the last 17 years.

Executives with significant control over the firm are: Hemlata M. owns 1/2 or less of company shares. Bharat M. owns 1/2 or less of company shares.

Financial data based on annual reports

Profit & Loss
Date of Accounts	2013-01-31	2014-01-31	2015-01-31	2016-01-31	2017-01-31	2018-01-31	2019-01-31	2020-01-31	2021-01-31	2022-01-31	2023-01-31
Currency
Net Worth	265 467	238 494	126 227	76 961

Balance Sheet
Cash Bank On Hand					465 619	355 707	426 737	579 558	690 658	881 696	1 000 117
Current Assets	491 902	474 342	444 899	489 714	627 573	523 914	594 728	693 691	886 905	1 000 490	1 158 217
Debtors	161 415	70 843	111 766	125 583	119 175	115 107	115 483	69 750	151 426	73 949	83 164
Net Assets Liabilities					63 432	91 914	89 216	108 328	184 414	300 330	393 423
Other Debtors					14 220	12 377	14 433
Property Plant Equipment					9 660	11 079	8 343	6 562	4 920	3 690	2 768
Total Inventories					42 779	53 100	52 508	44 383	44 821	44 845	74 936
Cash Bank In Hand	286 857	357 069	291 280	321 731
Intangible Fixed Assets	413 887	386 294	358 701	331 108
Net Assets Liabilities Including Pension Asset Liability	265 467	238 494	126 227	76 961
Stocks Inventory	43 630	46 430	41 853	42 400
Tangible Fixed Assets	4 365	3 274	8 005	9 118

Capital & Reserves
Called Up Share Capital	2	2	4	4
Profit Loss Account Reserve	265 465	238 492	126 223	76 957
Shareholder Funds	265 467	238 494	126 227	76 961

Other Financial Data
Accumulated Amortisation Impairment Intangible Assets					248 335	275 928	303 521	331 114	358 707	386 300	413 893
Accumulated Depreciation Impairment Property Plant Equipment					14 926	18 620	21 414	23 602	25 244	26 474	27 396
Amortisation Expense Intangible Assets					27 593	27 593	27 593
Amortisation Rate Used For Intangible Assets						5	5	5	5	5	5
Average Number Employees During Period							5	5	7	6	5
Comprehensive Income Expense					64 471	55 482	75 302
Corporation Tax Payable					22 393	19 355	24 778
Creditors					657 316	499 001	542 184	592 661	680 554	649 400	685 519
Depreciation Expense Property Plant Equipment					3 221	3 694	2 794
Depreciation Rate Used For Property Plant Equipment						25	25	25	25	25	25
Dividends Paid					78 000	27 000	78 000
Fixed Assets	418 252	389 568	366 706	340 226	313 175	287 001	256 672	227 298	198 063	169 240	140 725
Income Expense Recognised Directly In Equity					-78 000	-27 000	-78 000
Increase From Amortisation Charge For Year Intangible Assets						27 593	27 593	27 593	27 593	27 593	27 593
Increase From Depreciation Charge For Year Property Plant Equipment						3 694	2 794	2 188	1 642	1 230	922
Intangible Assets					303 515	275 922	248 329	220 736	193 143	165 550	137 957
Intangible Assets Gross Cost					551 850	551 850	551 850	551 850	551 850	551 850	551 850
Net Current Assets Liabilities	112 467	68 926	-20 479	-43 265	-29 743	24 913	52 544	101 030	206 351	351 090	472 698
Other Creditors					518 433	376 392	398 971
Other Taxation Social Security Payable					199	179	173
Profit Loss					64 471	55 482	75 302
Property Plant Equipment Gross Cost					24 586	29 699	29 757	30 164	30 164	30 164	30 164
Total Additions Including From Business Combinations Property Plant Equipment								407
Total Assets Less Current Liabilities	530 719	458 494	346 227	296 961	283 432	311 914	309 216	328 328	404 414	520 330	613 423
Trade Creditors Trade Payables					116 291	103 075	118 262
Trade Debtors Trade Receivables					104 955	102 730	101 050
Advances Credits Directors				303 950	323 950	243 301	225 306	222 157	208 712	408 770	397 575
Advances Credits Made In Period Directors					20 000	80 649	17 995	3 149	13 445	19 942
Creditors Due After One Year	265 000	220 000	220 000	220 000
Creditors Due Within One Year	379 435	405 416	465 378	532 979
Number Shares Allotted	2	2	1	1
Par Value Share		1	1	1
Provisions For Liabilities Charges	252
Intangible Fixed Assets Aggregate Amortisation Impairment		165 556	193 149	220 742
Intangible Fixed Assets Amortisation Charged In Period			27 593	27 593
Intangible Fixed Assets Cost Or Valuation		551 850	551 850	551 850
Secured Debts			220 000	220 000
Share Capital Allotted Called Up Paid		2	1	1
Tangible Fixed Assets Additions			8 894	10 823
Tangible Fixed Assets Cost Or Valuation		18 399	18 894	20 823
Tangible Fixed Assets Depreciation		15 125	10 889	11 705
Tangible Fixed Assets Depreciation Charged In Period			2 669	3 040
Tangible Fixed Assets Depreciation Decrease Increase On Disposals			6 905	2 224
Tangible Fixed Assets Disposals			8 399	8 894
Value Shares Allotted	2	2

Company staff

Hemlata M.

Role: Secretary

Appointed: 18 March 2007

Latest update: 28 March 2024

Bharat M.

Role: Director

Appointed: 18 March 2007

Latest update: 28 March 2024

People with significant control

Hemlata M.

Notified on 1 March 2017

Nature of control:

1/2 or less of shares

Bharat M.

Notified on 1 March 2017

Nature of control:

1/2 or less of shares

Accounts Documents

Account next due date	31 October 2024
Account last made up date	31 January 2023
Confirmation statement next due date	29 October 2024
Confirmation statement last made up date	15 October 2023

Annual Accounts
Start Date For Period Covered By Report	2013-02-01
End Date For Period Covered By Report	2014-01-31
Annual Accounts 13 October 2015
Start Date For Period Covered By Report	2014-02-01
End Date For Period Covered By Report	2015-01-31
Date Approval Accounts	13 October 2015
Annual Accounts 24 October 2016
Start Date For Period Covered By Report	2015-02-01
End Date For Period Covered By Report	2016-01-31
Date Approval Accounts	24 October 2016
Annual Accounts
Start Date For Period Covered By Report	2017-02-01
End Date For Period Covered By Report	31/01/2018
Annual Accounts
Start Date For Period Covered By Report	2018-02-01
End Date For Period Covered By Report	31/01/2019
Annual Accounts
Start Date For Period Covered By Report	2019-02-01
End Date For Period Covered By Report	31/01/2020
Annual Accounts
Start Date For Period Covered By Report	2020-02-01
End Date For Period Covered By Report	31/01/2021
Annual Accounts
Start Date For Period Covered By Report	2021-02-01
End Date For Period Covered By Report	31/01/2022
Annual Accounts
Start Date For Period Covered By Report	2022-02-01
End Date For Period Covered By Report	31/01/2023
Annual Accounts 31 October 2014
Date Approval Accounts	31 October 2014

J.t.smith & Son Pharma Limited

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Hemlata M.

Bharat M.

Hcs Secretarial Limited

Hanover Directors Limited

People with significant control

Hemlata M.

Bharat M.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Similar companies nearby

Closest companies